CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
34 hedge funds and large institutions have $45.5M invested in Cymabay Therapeutics in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
26% more funds holding
Funds holding: 27 → 34 (+7)
Holders
34
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$4.9M | |
| 2 | +$4.75M | |
| 3 | +$3.34M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$2.15M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$1.7M |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$353K | |
| 3 | -$215K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$14.1K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$7K |